Spire Healthcare Group (LON:SPI) Share Price Passes Below Fifty Day Moving Average - Time to Sell?

Key Points

• Spire Healthcare Group's stock price has fallen below its 50-day moving average of GBX 217.49, trading at GBX 214 with a low of GBX 208.50.
• Analysts have mixed ratings for Spire Healthcare, with Berenberg Bank maintaining a "buy" rating" and setting a price target of GBX 280, while JPMorgan Chase cut its price target to GBX 303.
• The company reported earnings of GBX 4.10 per share for the last quarter and has a market cap of £897.51 million with a net margin of 1.96%.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 217.49 ($2.95) and traded as low as GBX 208.50 ($2.83). Spire Healthcare Group shares last traded at GBX 214 ($2.90), with a volume of 428,582 shares traded.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Berenberg Bank restated a "buy" rating and set a GBX 280 ($3.80) price objective on shares of Spire Healthcare Group in a research note on Thursday, July 31st. JPMorgan Chase & Co. reduced their price objective on Spire Healthcare Group from GBX 309 ($4.19) to GBX 303 ($4.11) and set an "overweight" rating on the stock in a research note on Tuesday, August 5th.

Spire Healthcare Group Price Performance

The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The company has a market capitalization of £891.48 million, a P/E ratio of 31.60, a PEG ratio of 1.06 and a beta of 0.96. The business has a 50 day simple moving average of GBX 218.55 and a 200-day simple moving average of GBX 205.35.

Spire Healthcare Group (LON:SPI - Get Free Report) last posted its earnings results on Thursday, July 31st. The company reported GBX 4.10 ($0.06) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. Analysts predict that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.